Generalized Anxiety Disorder Market Research Report: Market size, Industry outlook, Market Forecast, Demand Analysis,Market Share, Market Report 2018-2023
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Generalized Anxiety Disorder Market
Generalized Anxiety Disorder Market: By Therapeutics Type (Antidepressant, Benzodiazepines, Others); By Therapies( Interpersonal Therapy, Behavior Therapy, Cognitive Behavioral Therapy, Mindfulness-based Cognitive Therapy); By devices (Deep Brain Stimulation, Electroconvulsive Therapy, Trans cranial Magnetic Stimulation, Vagus Nerve Stimulation (VNS)) & By Geography - Forecast(2018-2023)
Report Code : HCR 0216
Updated Date: 18 October, 2018  

1. Generalized Anxiety Disorder Market - Overview
1.1. Definitions and Scope
2. Generalized Anxiety Disorder Market - Executive summary
2.1. Market Revenue, Market Size and Key Trends by Company
2.2. Key Trends by type of Application
2.3. Key Trends segmented by Geography
3. Generalized Anxiety Disorder Market 
3.1. Comparative analysis
3.1.1. Product Benchmarking - Top 10 companies
3.1.2. Top 5 Financials Analysis
3.1.3. Market Value split by Top 10 companies
3.1.4. Patent Analysis - Top 10 companies
3.1.5. Pricing Analysis 
4. Generalized Anxiety Disorder Market – Startup companies Scenario
4.1. Top 10 startup company Analysis by
4.1.1. Investment
4.1.2. Revenue
4.1.3. Market Shares
4.1.4. Market Size and Application Analysis
4.1.5. Venture Capital and Funding Scenario
5. Generalized Anxiety Disorder Market – Industry Market Entry Scenario
5.1. Regulatory Framework Overview
5.2. New Business and Ease of Doing business index
5.3. Case studies of successful ventures
5.4. Customer Analysis – Top 10 companies
6. Generalized Anxiety Disorder Market Forces
6.1. Drivers
6.2. Constraints
6.3. Challenges
6.4. Porters five force model
6.4.1. Bargaining power of suppliers
6.4.2. Bargaining powers of customers
6.4.3. Threat of new entrants
6.4.4. Rivalry among existing players
6.4.5. Threat of substitutes 
7. Generalized Anxiety Disorder Market -Strategic analysis
7.1. Value chain analysis
7.2. Opportunities analysis
7.3. Product life cycle
7.4. Suppliers and distributors Market Share
8. Generalized Anxiety Disorder Market – By Therapeutics Type (Market Size -$Million / $Billion)
8.1. Market Size and Market Share Analysis 
8.2. Application Revenue and Trend Research
8.3. Product Segment Analysis
8.3.1. Antidepressant
8.3.1.1. Selective serotonin reuptake inhibitor (SSRI)
8.3.1.2. Serotonin norepinephrine reuptake inhibitor (SNRI)
8.3.1.3. Tricyclic antidepressant (TCA)
8.3.1.4. Monoamine Oxidase Inhibitors (MAOIs)
8.3.1.4.1. Benzodiazepines
8.3.1.4.2. Alprazolam
8.3.1.4.3. Chlordiazepoxide
8.3.1.4.4. Diazepam
8.3.1.4.5. Lorazepam
8.3.1.4.6. Others (Buspirone)
9. Generalized Anxiety Disorder Market – by Therapies type (Market Size -$Million / $Billion)
9.1. Interpersonal Therapy (IPT)
9.2. Behaviour Therapy
9.3. Cognitive Behavioral Therapy (CBT)
9.4. Mindfulness-based Cognitive Therapy (MBCT)
10. Generalized Anxiety Disorder Market – by Medical devices type (Market Size -$Million / $Billion)
10.1. Deep Brain Stimulation (DBS)
10.2. Electroconvulsive Therapy (ECT)
10.3. Trans cranial Magnetic Stimulation (TMS)
10.4. Vagus Nerve Stimulation (VNS)
11. Generalized Anxiety Disorder - By Geography (Market Size -$Million / $Billion)
11.1. Generalized Anxiety Disorder Market - North America Segment Research
11.2. North America Market Research (Million / $Billion)
11.2.1. Segment type Size and Market Size Analysis 
11.2.2. Revenue and Trends
11.2.3. Application Revenue and Trends by type of Application
11.2.4. Company Revenue and Product Analysis
11.2.5. North America Product type and Application Market Size
11.2.5.1. U.S.
11.2.5.2. Canada 
11.2.5.3. Mexico 
11.2.5.4. Rest of North America
11.3. Generalized Anxiety Disorder - South America Segment Research
11.4. South America Market Research (Market Size -$Million / $Billion)
11.4.1. Segment type Size and Market Size Analysis 
11.4.2. Revenue and Trends
11.4.3. Application Revenue and Trends by type of Application
11.4.4. Company Revenue and Product Analysis
11.4.5. South America Product type and Application Market Size
11.4.5.1. Brazil  
11.4.5.2. Venezuela
11.4.5.3. Argentina
11.4.5.4. Ecuador
11.4.5.5. Peru
11.4.5.6. Colombia 
11.4.5.7. Costa Rica
11.4.5.8. Rest of South America
11.5. Generalized Anxiety Disorder - Europe Segment Research
11.6. Europe Market Research (Market Size -$Million / $Billion)
11.6.1. Segment type Size and Market Size Analysis 
11.6.2. Revenue and Trends
11.6.3. Application Revenue and Trends by type of Application
11.6.4. Company Revenue and Product Analysis
11.6.5. Europe Segment Product type and Application Market Size
11.6.5.1. U.K  
11.6.5.2. Germany 
11.6.5.3. Italy 
11.6.5.4. France
11.6.5.5. Netherlands
11.6.5.6. Belgium
11.6.5.7. Spain
11.6.5.8. Denmark
11.6.5.9. Rest of Europe
11.7. Generalized Anxiety Disorder – APAC Segment Research
11.8. APAC Market Research (Market Size -$Million / $Billion)
11.8.1. Segment type Size and Market Size Analysis 
11.8.2. Revenue and Trends
11.8.3. Application Revenue and Trends by type of Application
11.8.4. Company Revenue and Product Analysis
11.8.5. APAC Segment – Product type and Application Market Size
11.8.5.1. China 
11.8.5.2. Australia
11.8.5.3. Japan 
11.8.5.4. South Korea
11.8.5.5. India
11.8.5.6. Taiwan
11.8.5.7. Malaysia
12. Generalized Anxiety Disorder Market - Entropy
12.1. New product launches
12.2. M&A's, collaborations, JVs and partnerships
13. Generalized Anxiety Disorder Market – Industry / Segment Competition landscape
13.1. Market Share Analysis
13.1.1. Market Share by Country- Top companies
13.1.2. Market Share by Region- Top 10 companies
13.1.3. Market Share by type of Application – Top 10 companies
13.1.4. Market Share by type of Product / Product category- Top 10 companies
13.1.5. Market Share at global level- Top 10 companies
13.1.6. Best Practises for companies
14. Generalized Anxiety Disorder Market – Key Company List by Country
15. Generalized Anxiety Disorder Market Company Analysis
15.1. Market Share, Company Revenue, Products, M&A, Developments
15.2. GlaxoSmithKline Pharmaceuticals Limited
15.3. Bristol-Myers Squibb
15.4. Sumitomo Dainippon Pharma
15.5. Noven Pharmaceuticals, Inc.
15.6. Actavis Pharmaceutical Company
15.7. F. Hoffmann-La Roche
15.8. Abbott Laboratories
15.9. Eli Lilly and Company
15.10. Pfizer Inc.
15.11. Shionogi and Company
15.12. Company 11
15.13. Company 12
15.14. Company 13 and more
"*Financials would be provided on a best efforts basis for private companies"
16. Generalized Anxiety Disorder Market -Appendix
16.1. Abbreviations
16.2. Sources
17. Generalized Anxiety Disorder Market -Methodology
17.1. Research Methodology
17.1.1. Company Expert Interviews
17.1.2. Industry Databases
17.1.3. Associations
17.1.4. Company News
17.1.5. Company Annual Reports
17.1.6. Application Trends
17.1.7. New Products and Product database
17.1.8. Company Transcripts
17.1.9. R&D Trends
17.1.10. Key Opinion Leaders Interviews
17.1.11. Supply and Demand Trends
Please select Licence
Single User Licence:
US $5250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll